Company intelligence
Novartis
About Novartis
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki
Verified activity
Signals from Novartis
44 published signals
Partnerships
Novartis and The Max Foundation have partnered for 25 years to help ensure cancer care breakthroughs reach more patients around the world.
Reported by Novartis
Research & Knowledge
Novartis published in the journal NEJM the clinical trial JY231 for lentiviral in vivo CD19 CAR T-cell therapy in neurologic autoimmune disorders.
Reported by Ettore Biagi
People
Novartis appointed Gloria F. as Director Strategy International, leading strategic initiatives across International markets.
Reported by Gloria F.
Presence & Recognition
Novartis is attending SFC Europe 2026 in Basel, with an SFC short course on October 4.
Reported by Larry Miller
People
Novartis is hiring for two critical leadership roles for the AI Systems Foundations & Reusable Capabilities and AI Systems Reliability, Testing & Performance teams.
Reported by Sander Timmer, PhD
Presence & Recognition
Novartis participated in the Affirmation of the Day and Perspective of the Day events.
Reported by Sujatha Ramanathan
People
Novartis is expanding its Medical Affairs team at Theramex with two new Medical Science Liaison opportunities.
Reported by Ana Filipa Sousa
People
Novartis is hiring a Data Management & Infrastructure Manager with experience in Snowflake or similar cloud data platforms, Medallion architecture, bronze, silver, and gold data layers, SQL, ETL/ELT processes, data pipelines, and cloud data warehouse concepts.
Reported by Marianne Owen
Presence & Recognition
Novartis announced the company's presence in Mystic, Connecticut.
Reported by Kim Deer CPA
Presence & Recognition
Novartis participated in the Message of the Day event
Reported by Sujatha Ramanathan
Research & Knowledge
Novartis published the Policy and Practice Review by Larsen and colleagues, which provides a blueprint for connecting local, regional, and global evidence-generation capabilities.
Reported by Michael Dreiseidler
Presence & Recognition
Novartis announced the company's presence in Traverse City, Michigan.
Reported by Kim Deer CPA
Presence & Recognition
Novartis participated in the Messsageoftheday event.
Reported by Sujatha Ramanathan
Presence & Recognition
Novartis participated in the Affirmation of the Day and Perspective of the Day events.
Reported by Sujatha Ramanathan
Research & Knowledge
Novartis cardiovascular research includes the VictORION clinical program investigating inclisiran across the ASCVD continuum, including major cardiovascular-outcomes studies in prevention.
Reported by Marin Pavić
Operations & Supply
Novartis saved the account and went on to save the company several million in costs by delivering a critical infrastructure project with a team from various departments and countries.
Reported by Dr. Steven Partridge
Presence & Recognition
Novartis U.S. Commercial leaders attended a Microsoft visit to learn about AI reshaping work and the importance of curiosity, safety, experimentation, and self-transformation.
Reported by Nancy Shore DiLella
Partnerships
Novartis partnered with FHI 360 as the Beacon of Hope Coordinating Center.
Reported by Ashley Atkins, Ph.D.
Strategy & Corporate Development
Novartis is developing a new platform for the clinical trial of a new drug.
Reported by Mahwish Natalia, MA, PhD
Presence & Recognition
Novartis will present a case study on Innovation in the Age of AI at AES in Atlanta on October 14
Reported by Xavier Hansen
Research & Knowledge
Novartis published in the New England Journal of Medicine (NEJM) the trial of azacitidine-venetoclax or induction chemotherapy for acute myeloid leukemia (AML) with a high risk of an event or death.
Reported by Ettore Biagi
Operations & Supply
Novartis is installing new steam-powered diesel kesselhauser in Kundl and Schaftenau to achieve net-zero emissions by 2040.
Reported by Roland Gander
Presence & Recognition
Novartis Ireland highlighted AI as a key driver of innovation and digital transformation.
Reported by David Nugent
Presence & Recognition
Novartis Adriatic team is attending a Cycle Meeting in Zagreb to discuss customer experiences and the Human Advantage.
Reported by Cristina Finazzi